Quick Answer
Alpha-Lipoic Acid Exercise Recovery Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: This systematic review synthesized current evidence regarding the reversal of cardiovascular risk biomarkers after smoking cessation, with emphasis on the timing and magnitude of biomarker normalization.
Key Takeaways
- 01This systematic review synthesized current evidence regarding the reversal of cardiovascular risk biomarkers after smoking cessation, with emphasis on the timing and magnitude of biomarker normalization. [Mohammad A (2026)]
- 02Risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB 2) tool and the Risk of Bias in Nonrandomized Studies-of Interventions (ROBINS-I) instrument, and findings were synthesized narratively because of methodological heterogeneity. [Mohammad A (2026)]
- 03Overall, smoking cessation was associated with progressive improvement in multiple cardiovascular risk pathways, supporting its critical role in cardiovascular prevention and highlighting the potential value of biomarker-guided approaches in future risk-reduction strategies. [Mohammad A (2026)]
- 04Cigarette smoking remains a major modifiable contributor to cardiovascular morbidity and mortality through mechanisms involving systemic inflammation, oxidative stress, endothelial dysfunction, dyslipidemia, and hematologic abnormalities. [Mohammad A (2026)]
The current Migaku evidence database contains 2 reusable source documents for Alpha-Lipoic Acid Exercise Recovery Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- This systematic review synthesized current evidence regarding the reversal of cardiovascular risk biomarkers after smoking cessation, with emphasis on the timing and magnitude of biomarker normalization. [Mohammad A (2026); evidence level 1]
- Risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB 2) tool and the Risk of Bias in Nonrandomized Studies-of Interventions (ROBINS-I) instrument, and findings were synthesized narratively because of methodological heterogeneity. [Mohammad A (2026); evidence level 1]
- Overall, smoking cessation was associated with progressive improvement in multiple cardiovascular risk pathways, supporting its critical role in cardiovascular prevention and highlighting the potential value of biomarker-guided approaches in future risk-reduction strategies. [Mohammad A (2026); evidence level 1]
- Cigarette smoking remains a major modifiable contributor to cardiovascular morbidity and mortality through mechanisms involving systemic inflammation, oxidative stress, endothelial dysfunction, dyslipidemia, and hematologic abnormalities. [Mohammad A (2026); evidence level 1]
- This systematic review aimed to synthesize current clinical evidence on dietary supplementation for OS management in young adults undergoing intensive exercise and to evaluate study methodology critically. [Kakouris V (2026); evidence level 1]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources